In a significant corporate move, Bridgepoint, through its Bridgepoint Development Capital V fund, has reinvested in Brevo, a European customer engagement software platform, as part of a €500 million financing round. This investment has elevated Brevo to unicorn status for the first time, reflecting its rapid growth and potential in the customer engagement sector.
Bridgepoint's reinvestment comes after it fully realized its original minority stake from Bridgepoint Development Capital III, which first backed Brevo in 2020. Now, Brevo's management and employees have emerged as the largest shareholders, signaling strong internal confidence in the company's future. General Atlantic and Oakley Capital are also joining Bridgepoint as shareholders in this latest funding round.
While specific financial terms have not been disclosed, the deal is expected to facilitate Brevo's ambitious growth trajectory, with an annual recurring revenue (ARR) forecast to surpass €200 million by 2025, representing a fivefold increase since 2020. The company is also anticipating double-digit EBITDA margins, driven by product innovation and expansion beyond its core email services into areas such as CRM, marketing automation, and multi-channel capabilities. Since Bridgepoint's initial investment, Brevo has successfully completed nine bolt-on acquisitions, further diversifying its offerings.
The new capital will enable Brevo to accelerate its international strategy, particularly scaling operations in North America, invest in large-scale AI-driven product capabilities, and pursue targeted mergers and acquisitions to enhance its platform. The company aims for a substantial target of €1 billion in annual revenue by 2030.
The transaction, which completed in November 2025, involved advisory support from notable firms including Evercore and Goldman Sachs for Brevo, and Moelis & Company for Bridgepoint. Additional advisory support included Proskauer for legal matters and McKinsey for commercial strategy related to Bridgepoint Development Capital V, as well as Alvarez & Marsal for financial guidance.
As Brevo gears up for its next phase of growth, the implications for shareholders and employees are likely to be positive, given the company’s strong market position and strategic initiatives. However, as with any substantial corporate action, regulatory approvals may be necessary, particularly regarding antitrust considerations, although no specific challenges have been highlighted in the current deal structure.
Overall, this reinvestment underscores Bridgepoint's commitment to supporting fast-growing businesses in Europe and positions Brevo as a formidable player in the customer engagement software market.